Minimum information about a bioactive entity (MIABE). - Wikidata - awgldk - TriplyDB

Minimum information about a bioactive entity (MIABE).

Minimum information about a bioactive entity (MIABE).

http://www.wikidata.org/entity/Q34212022

about

Data integration in biological research: an overview Reporting biological assay screening results for maximum impact An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines Practice and Challenges of Building a Semantic Framework for Chemogenomics Research A brief review of recent Charcot-Marie-Tooth research and priorities InChI in the wild: an assessment of InChIKey searching in Google How should the completeness and quality of curated nanomaterial data be evaluated?Many InChIs and quite some feat Annotating Human P-Glycoprotein Bioassay Data Cheminformatics Research at the Unilever Centre for Molecular Science Informatics Cambridge Activity, assay and target data curation and quality in the ChEMBL database Development of data representation standards by the human proteome organization proteomics standards initiative Taking Open Innovation to the Molecular Level - Strengths and Limitations Improving integrative searching of systems chemical biology data using semantic annotation Behavioral barcoding in the cloud: embracing data-intensive digital phenotyping in neuropharmacology Exploiting open data: a new era in pharmacoinformatics.Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High-Throughput Screening Data from the Library of Integrated Network-based Cellular Signatures (LINCS).Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation.Translational informatics: an industry perspective.Quality Issues with Public Domain Chemogenomics Data.Characterisation of data resources for in silico modelling: benchmark datasets for ADME properties.First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine Molecular interaction databases.Graphs and networks in chemical and biological informatics: past, present and future.Exploitation of genomics in fungicide research: current status and future perspectives.Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts.canSAR: an integrated cancer public translational research and drug discovery resource Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway.Leishmania and other intracellular pathogens: selectivity, drug distribution and PK-PD.VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization.Propelling the paradigm shift from reductionism to systems nutrition.From proteomics data representation to public data flow: a report on the HUPO-PSI workshop September 2011, Geneva, Switzerland.In vivo genotoxicity and cytotoxicity assessment of a novel quinoxalinone with trichomonacide activity.Deriving bio-equivalents from in vitro bioassays: assessment of existing uncertainties and strategies to improve accuracy and reporting.Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions.Advancing the drug discovery and development process.The Alexandria library, a quantum-chemical database of molecular properties for force field development.Challenges of Connecting Chemistry to Pharmacology: Perspectives from Curating the IUPHAR/BPS Guide to PHARMACOLOGY Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group

P2860

Q26785948-1D892F0D-2A27-4D85-8912-FDC83F88D9EC Q26801607-6D0A65AD-2818-48C1-9D5B-AA4B5EA13333 Q26827563-EE245C43-3114-401F-A0ED-C7140A810EF4 Q27009058-7572BA49-334D-4BBD-9394-9E040637943F Q27012700-E3DF1410-6662-43CD-A429-7B62D2C3FE64 Q27818912-4BAA540C-40C2-47C6-A29D-B25515F21033 Q27908490-0906A4C0-3868-4417-9EE2-797AE2155D09 Q27943500-A784652D-CD34-4A9D-ADEF-8A6F783A129B Q27967903-BC7A390C-11EA-4EE9-9C94-31005EB34FB2 Q28607245-9D09EA99-B637-47B1-8C2F-82410C946316 Q28611248-6B5DBEB8-210C-43C9-A7AF-09F4F40A6B62 Q28645794-B7AEDD79-31CA-4A09-A596-2755AE8FB76B Q28710516-0A59CD13-6F38-41B1-BC9F-D448CD6E1701 Q28730732-01536CF9-E4E6-46CC-8936-C100E0AB8D6C Q30451663-B051BC6D-7A3B-48A0-A8FD-6ECE5CEDEDAD Q30486817-8800C9C1-0BFC-415D-8259-B0CE46B499AF Q30755333-9AD3BAE8-0A14-4974-9098-E388173F7814 Q31106801-CA67CBAB-7EE4-472A-9582-E1A4404AE781 Q35751251-59964FE2-A8D4-43A2-ACDB-D1405D832615 Q36092094-2D9D9D4B-4976-460E-91F5-2D97C0FE7158 Q36333632-36983D2A-424B-4033-9D70-84F8689F372F Q37272419-81374A4D-8AA5-4901-A71F-2A86FFBB9533 Q38011667-7F8D28B5-0C9C-4444-8C25-70B16DC3C5A6 Q38060184-664C0A39-C0BD-47BA-B2BC-3A7016F6BAAE Q38060200-702E77E3-A239-4509-A1CD-1C3837F5C845 Q38915525-F3C75A31-54B8-4E56-9766-AD849BA36B22 Q39455504-13EFE624-2BF3-44F5-B9B1-008AC8273D3E Q40046136-B3B78788-472A-4997-807D-83B5441BA768 Q41990715-B2F4AC48-1BD3-4FA5-A477-5C1FA0F5BA39 Q42278847-FCDF3D9C-4E33-48BC-B1C3-541F3A281E92 Q42328113-708FB6A3-3B4A-49CF-9BC8-FCC6408DDB9C Q42634358-92066526-0D07-46B4-AA50-44540496DF06 Q45985861-E0F22009-DD33-4D42-AB48-38B058D3FB43 Q45987106-73DE54CC-D109-4A90-870E-F70341558221 Q47252031-5D156CD6-2B1A-4679-80DB-5EB57177AED8 Q47747820-84A49964-F9C5-4271-AF9C-0B4BD167DDE8 Q53831374-86416F1F-30A5-4777-A6D2-0CDE2C792B0A Q56762855-30BDCC42-EACD-4429-B753-D6B06D84E65A Q56881081-878ED7FE-27DF-4680-B0BE-0459C156B644

P2860

Minimum information about a bioactive entity (MIABE).

http://www.wikidata.org/entity/Q34212022

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Minimum information about a bioactive entity (MIABE).

@ast

Minimum information about a bioactive entity (MIABE).

@en

Minimum information about a bioactive entity

@nl

type

label

Minimum information about a bioactive entity (MIABE).

@ast

Minimum information about a bioactive entity (MIABE).

@en

Minimum information about a bioactive entity

@nl

prefLabel

Minimum information about a bioactive entity (MIABE).

@ast

Minimum information about a bioactive entity (MIABE).

@en

Minimum information about a bioactive entity

@nl

P1433

Q34212022-987DF567-E18A-4814-8549-13B5AE8BF91A

P1476

Q34212022-6DD6623A-84E3-46B8-AFD6-1F68CFBFB6C9

P2093

Q34212022-1C3CDB6C-3A90-4DD5-AE70-160942FFD84B

Q34212022-2EE69DA0-E947-4D6B-9599-B50A90A5D8E3

Q34212022-45F2C0B8-C064-4BAE-8E4F-94DF4A1D3D2B

Q34212022-48BE7FD1-6345-4A95-93BD-B5E555EDF9B6

Q34212022-67908105-FC67-4CA5-AB67-1E9B987A13B5

Q34212022-902C37A7-131C-4858-A9D3-CFF57C8BA92C

Q34212022-BB96FE2A-D3C6-41E1-AD53-6FFACB841A27

Q34212022-C00EA890-C360-4F60-97F9-F37F73459496

Q34212022-CAC3BA0F-931E-4BE8-A70B-E5963E312603

Q34212022-D984720F-A7FA-4EC0-BB25-6B53CB99A912

P2860

Q34212022-04EC4F9C-F127-4FC0-B777-C350BA0FA610

Q34212022-0DF51E46-18E5-48FE-92EC-100D97B455E2

Q34212022-14D12C10-0184-4925-9431-58F1F19084F1

Q34212022-1FBFC7B6-EAD0-4AF2-A35A-4731A496B00C

Q34212022-2D343B27-4525-4A78-B8DD-CB641B0C63B0

Q34212022-497BC730-C1B5-4D33-B7CA-917B885260A8

Q34212022-59311727-4DE0-41C3-BFA8-B22C10B4288F

Q34212022-6307A142-A470-4D60-9753-112B6A970920

Q34212022-63A50088-28AC-404B-9627-A21AFA5AF4EC

Q34212022-6498BF89-0DCD-4EB1-AEE1-7DE48B984227

P2888

Q34212022-70166641-398C-455D-B182-AE47C398B596

P304

Q34212022-399D3A36-6A6E-480A-B188-229900E4F2DA

P31

Q34212022-0C9B762C-F864-4146-B5D6-FEAC3958D51E

P356

Q34212022-248E7206-DFD9-434F-8A9D-380406279BE4

P433

Q34212022-FC1854DC-52D2-43CE-ACBD-820270348703

P478

Q34212022-ACD1BECF-480A-4BEF-8D75-481B5BD92D99

P50

Q34212022-05C62639-8E29-4228-A5B7-72CA258CD85A

Q34212022-35644636-BADE-435E-BD78-B680D32E67A1

Q34212022-51F29A0F-3D55-4E6F-BBE1-EA13B2D77F20

Q34212022-5827741C-4EA6-4663-9210-5EE383CBBCA2

Q34212022-6CFCE4F8-19AA-40F8-A2C6-8B0D70A3DF06

Q34212022-78FCE4F3-EA56-4E42-B7E9-986646832DB6

Q34212022-97AB1497-A6F5-4A9F-A90C-7C52A5DFDEB0

Q34212022-9AEE103D-5C2A-43DF-A244-BF96F3EDBB0C

Q34212022-A54F035E-CCCE-4466-934A-923DF95066DD

Q34212022-B001A85C-5AAD-455A-ACD7-40F6676E8A47

P577

Q34212022-A6A522A9-F218-42F4-B451-730452C08F14

P5875

Q34212022-5443AD3D-AA5D-4BFD-83ED-B26E752849EF

P698

Q34212022-7009477D-98EA-4B8B-A10D-8ACEBE52939B

P356

P1433

Nature Reviews Drug Discovery

P1476

Minimum information about a bioactive entity (MIABE).

@en

P2093

Andrew Hopkins

http://www.w3.org/2001/XMLSchema#string

Christopher Larminie

http://www.w3.org/2001/XMLSchema#string

Elena Lo Piparo

http://www.w3.org/2001/XMLSchema#string

Elizabeth Calder

http://www.w3.org/2001/XMLSchema#string

Ian Dix

http://www.w3.org/2001/XMLSchema#string

Mark Forster

http://www.w3.org/2001/XMLSchema#string

Martin Grigorov

http://www.w3.org/2001/XMLSchema#string

Michael Gilson

http://www.w3.org/2001/XMLSchema#string

Robert Glen

http://www.w3.org/2001/XMLSchema#string

Romeena K Mann

http://www.w3.org/2001/XMLSchema#string

P2860

The genome of the blood fluke Schistosoma mansoni

Database resources of the National Center for Biotechnology Information

ChEBI: a database and ontology for chemical entities of biological interest

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

How many drug targets are there?

Reactome: a database of reactions, pathways and biological processes

PSICQUIC and PSISCORE: accessing and scoring molecular interactions

Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project

The druggable genome

P2888

P304

661-669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRD3503

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

David S Wishart

Christopher Southan

Henning Hermjakob

John P. Overington

Bissan Al-Lazikani

P577

2011-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51606759

http://www.w3.org/2001/XMLSchema#string

P698

21878981

http://www.w3.org/2001/XMLSchema#string